119 related articles for article (PubMed ID: 32376423)
1. Height, nevus count, and risk of cutaneous malignant melanoma: Results from 2 large cohorts of US women.
Li X; Kraft P; De Vivo I; Giovannucci E; Liang L; Nan H
J Am Acad Dermatol; 2020 Oct; 83(4):1049-1056. PubMed ID: 32376423
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous nevi and internal cancer risk: Results from two large prospective cohorts of US women.
Li X; Wu W; Giovannucci E; Stampfer MJ; Gao X; Han J
Int J Cancer; 2020 Jul; 147(1):14-20. PubMed ID: 31593602
[TBL] [Abstract][Full Text] [Related]
3. Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma.
Wei EX; Li X; Nan H
J Am Acad Dermatol; 2019 Apr; 80(4):970-978. PubMed ID: 30713015
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous nevi and risk of melanoma death in women and men: A prospective study.
Li WQ; Cho E; Weinstock MA; Li S; Stampfer MJ; Qureshi AA
J Am Acad Dermatol; 2019 May; 80(5):1284-1291. PubMed ID: 30639880
[TBL] [Abstract][Full Text] [Related]
5. Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease.
Bain C; Colditz GA; Willett WC; Stampfer MJ; Green A; Bronstein BR; Mihm MC; Rosner B; Hennekens CH; Speizer FE
Am J Epidemiol; 1988 Apr; 127(4):703-12. PubMed ID: 3354537
[TBL] [Abstract][Full Text] [Related]
6. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
7. High nevus counts confer a favorable prognosis in melanoma patients.
Ribero S; Davies JR; Requena C; Carrera C; Glass D; Rull R; Vidal-Sicart S; Vilalta A; Alos L; Soriano V; Quaglino P; Traves V; Newton-Bishop JA; Nagore E; Malvehy J; Puig S; Bataille V
Int J Cancer; 2015 Oct; 137(7):1691-8. PubMed ID: 25809795
[TBL] [Abstract][Full Text] [Related]
8. Comparison of phenotypic features in patients with single vs multiple primary cutaneous melanomas: a prospective single-center study.
Farabi B; Bostanci S; Akay BN; Caliskan D; Atak MF
Int J Dermatol; 2023 Jan; 62(1):66-72. PubMed ID: 36254676
[TBL] [Abstract][Full Text] [Related]
9. Associations between benign cutaneous nevi and risk of Type 2 diabetes mellitus in men and women: results from two prospective cohort studies.
Dai H; Sun Q; Zhang C; Zhang X; Li WQ; Manson JE; Hu FB; Song Y
Diabet Med; 2017 Jul; 34(7):925-933. PubMed ID: 27917515
[TBL] [Abstract][Full Text] [Related]
10. Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers.
Geller AC; Mayer JE; Sober AJ; Miller DR; Argenziano G; Johnson TM; Swetter SM
JAMA Dermatol; 2016 Apr; 152(4):413-8. PubMed ID: 26934430
[TBL] [Abstract][Full Text] [Related]
11. Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign.
Suppa M; Gandini S; Njimi H; Bulliard JL; Correia O; Duarte AF; Peris K; Stratigos AJ; Nagore E; Longo MI; Bylaite-Bucinskiene M; Karls R; Helppikangas H; ; Del Marmol V
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():76-88. PubMed ID: 30811689
[TBL] [Abstract][Full Text] [Related]
12. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate.
Tsao H; Bevona C; Goggins W; Quinn T
Arch Dermatol; 2003 Mar; 139(3):282-8. PubMed ID: 12622618
[TBL] [Abstract][Full Text] [Related]
13. Prediction of high naevus count in a healthy U.K. population to estimate melanoma risk.
Ribero S; Zugna D; Osella-Abate S; Glass D; Nathan P; Spector T; Bataille V
Br J Dermatol; 2016 Feb; 174(2):312-8. PubMed ID: 26479165
[TBL] [Abstract][Full Text] [Related]
14. Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician.
Lawson DD; Moore DH; Schneider JS; Sagebiel RW
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):438-44. PubMed ID: 8077469
[TBL] [Abstract][Full Text] [Related]
15. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women.
Weinstock MA; Colditz GA; Willett WC; Stampfer MJ; Bronstein BR; Mihm MC; Speizer FE
J Natl Cancer Inst; 1989 Jun; 81(12):948-52. PubMed ID: 2733040
[TBL] [Abstract][Full Text] [Related]
16. Nevi, family history, and fair skin increase the risk of second primary melanoma.
Siskind V; Hughes MC; Palmer JM; Symmons JM; Aitken JF; Martin NG; Hayward NK; Whiteman DC
J Invest Dermatol; 2011 Feb; 131(2):461-7. PubMed ID: 20944647
[TBL] [Abstract][Full Text] [Related]
17. Anthropometric features and cutaneous melanoma risk: a prospective cohort study in French women.
Kvaskoff M; Bijon A; Mesrine S; Vilier A; Clavel-Chapelon F; Boutron-Ruault MC
Cancer Epidemiol; 2014 Aug; 38(4):357-63. PubMed ID: 24986641
[TBL] [Abstract][Full Text] [Related]
18. Host Characteristics and Risk of Incident Melanoma by Breslow Thickness.
Li WQ; Cho E; Wu S; Li S; Matthews NH; Qureshi AA
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):217-224. PubMed ID: 30341099
[TBL] [Abstract][Full Text] [Related]
19. Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.
Taylor NJ; Thomas NE; Anton-Culver H; Armstrong BK; Begg CB; Busam KJ; Cust AE; Dwyer T; From L; Gallagher RP; Gruber SB; Nishri DE; Orlow I; Rosso S; Venn AJ; Zanetti R; Berwick M; Kanetsky PA;
Int J Cancer; 2016 Sep; 139(6):1217-22. PubMed ID: 27101944
[TBL] [Abstract][Full Text] [Related]
20. Effect of neonatal phototherapy on melanocytic nevus count in children.
Matichard E; Le Hénanff A; Sanders A; Leguyadec J; Crickx B; Descamps V
Arch Dermatol; 2006 Dec; 142(12):1599-604. PubMed ID: 17178986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
